Trial Profile
A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of EC-MPS with basiliximab corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Jan 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 23 Nov 2005 New trial record.